BioNTech SE Net Tangible Assets

BioNTech SE (BNTX) currently reports a net tangible assets of $19B as of March 2026. That compares with $19B in the prior-year period — down 1.1% year over year. Use the charts on this page to explore BioNTech SE's net tangible assets history and peer comparisons.

BioNTech SE's net tangible assets decreased from $19B to $19B — a 1.1% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioNTech SE reported $19B in net tangible assets as of March 2026. That compares with $19B in the prior-year period — down 1.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $19B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioNTech SE, and consider following BNTX for alerts when major investors trade the stock.

BioNTech SE is classified in the Healthcare sector. On net tangible assets, it currently shows $19B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BNTX with unrelated industries.